Qube Research & Technologies (QRT)
REPL icon

Qube Research & Technologies (QRT)’s Replimune Group REPL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,805
Closed -$500K – 3885
2025
Q2 		$500K Buy
53,805
+1,025
+2% +$8.94K ﹤0.01% 2696
2025
Q1 		$515K Buy
+52,780
New +$653K ﹤0.01% 2533
2024
Q2 		– Sell
-221,222
Closed -$1.81M – 4567
2024
Q1 		$1.81M Sell
221,222
-173,494
-44% -$1.42M ﹤0.01% 1818
2023
Q4 		$3.33M Buy
+394,716
New +$4.58M 0.01% 1259
2023
Q2 		– Sell
-99,182
Closed -$1.75M – 2904
2023
Q1 		$1.75M Buy
+99,182
New +$2.36M 0.01% 1061
2022
Q2 		– Sell
-49,090
Closed -$834K – 3027
2022
Q1 		$834K Buy
+49,090
New +$926K 0.01% 1259
2021
Q4 		– Sell
-7,131
Closed -$211K – 2892
2021
Q3 		$211K Buy
+7,131
New +$232K ﹤0.01% 1643
2021
Q2 		– Sell
-12,819
Closed -$391K – 2718
2021
Q1 		$391K Buy
+12,819
New +$480K 0.01% 1318

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s REPL Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 53,805 shares — an estimated $500K sold.

Qube Research & Technologies (QRT) first reported a position in REPL in Q1 2021 and held it in 8 quarters. The position peaked at $3.33M in Q4 2023. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 53,805 Replimune Group shares in Q3 2025, an estimated $500K.
  • Qube Research & Technologies (QRT) first reported a position in Replimune Group in Q1 2021 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Replimune Group position peaked at $3.33M in Q4 2023.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.